Tenascin-C Protein (Tenascin-C, TNC)
Introduction
flowchart TD
TENASCINCPROTEIN["TENASCINCPROTEIN"] -->|"associated with"| TREM2["TREM2"]
TENASCINCPROTEIN["TENASCINCPROTEIN"] -->|"associated with"| microglia["microglia"]
style TENASCINCPROTEIN fill:#4fc3f7,stroke:#333,color:#000
<table class="infobox infobox-protein"> <tr> <th class="infobox-header" colspan="2">Tenascin-C Protein (Tenascin-C, TNC)</th> </tr> <tr> <td class="label">Gene </td> <td>TNC (no dedicated gene page)</td> </tr> <tr> <td class="label">UniProt </td> <td>[P24821](https://www.uniprot.org/uniprot/P24821)</td> </tr> <tr> <td class="label">Molecular Weight </td> <td>~190-220 kDa (subunit), ~1,000 kDa (hexamer)</td> </tr> <tr> <td class="label">Subcellular Localization </td> <td>Extracellular matrix</td> </tr> <tr> <td class="label">Protein Family </td> <td>Tenascin family</td> </tr> <tr> <td class="label">Aliases </td> <td>Tenascin-C, TNC, Cytotactin, Hexabrachion</td> </tr> <tr> <td class="label">Approach</td> <td>Description</td> </tr> <tr> <td class="label">Anti-tenascin antibodies</td> <td>Tumor-targeted therapy</td> </tr> <tr> <td class="label">Peptide antagonists</td> <td>Block tenascin-integrin interactions</td> </tr> <tr> <td class="label">Gene therapy</td> <td>Modulate tenascin-C expression</td> </tr> </table>
...
Tenascin-C Protein (Tenascin-C, TNC)
Introduction
Mermaid diagram (expand to render)
<table class="infobox infobox-protein"> <tr> <th class="infobox-header" colspan="2">Tenascin-C Protein (Tenascin-C, TNC)</th> </tr> <tr> <td class="label">Gene </td> <td>TNC (no dedicated gene page)</td> </tr> <tr> <td class="label">UniProt </td> <td>[P24821](https://www.uniprot.org/uniprot/P24821)</td> </tr> <tr> <td class="label">Molecular Weight </td> <td>~190-220 kDa (subunit), ~1,000 kDa (hexamer)</td> </tr> <tr> <td class="label">Subcellular Localization </td> <td>Extracellular matrix</td> </tr> <tr> <td class="label">Protein Family </td> <td>Tenascin family</td> </tr> <tr> <td class="label">Aliases </td> <td>Tenascin-C, TNC, Cytotactin, Hexabrachion</td> </tr> <tr> <td class="label">Approach</td> <td>Description</td> </tr> <tr> <td class="label">Anti-tenascin antibodies</td> <td>Tumor-targeted therapy</td> </tr> <tr> <td class="label">Peptide antagonists</td> <td>Block tenascin-integrin interactions</td> </tr> <tr> <td class="label">Gene therapy</td> <td>Modulate tenascin-C expression</td> </tr> </table>
Tenascin-C (TNC) is a large hexameric extracellular matrix (ECM) glycoprotein expressed during embryonic development and re-expressed in various pathological conditions including wound healing, inflammation, and cancer. In the nervous system, Tenascin-C plays important roles in neural development, synaptic plasticity, and regenerative responses following injury. It is also implicated in the pathogenesis of neurodegenerative diseases and gliomas.
:: infobox .infobox-protein ===
Structure
Domain Architecture Tenascin-C is a large, multifunctional glycoprotein with a complex structure:
N-terminal heptad domain : Mediates hexamer formation (6 subunits)
Epidermal growth factor (EGF)-like repeats : 13.5 repeats (14-15 total)
Fibronectin type III (FNIII) repeats : 15 repeats (variable splicing)
C-terminal fibrinogen globe (FBG) : Mediates protein-protein interactions
Alternative Splicing Tenascin-C undergoes extensive alternative splicing:
Inclusion/exclusion of FNIII repeats : Creates isoforms with different binding properties
Variable expression : Different isoforms in development vs. adult tissue
Functional implications : Isoform-specific interactions with integrins and other ECM proteins
Assembly
Forms a hexameric "hexabrachion" structure
Six subunits connected at the N-terminal termini
Creates a star-like appearance under electron microscopy
Normal Function
Neural Development Tenascin-C is highly expressed during embryonic development:
Axon guidance : Provides guidance cues for growing axons
Cell adhesion : Mediates neuronal-glial interactions
Neural crest cell migration : Important for neural crest derivation
Cortical development : Regulates neuronal positioning
Synaptic Function In the mature nervous system:
Synaptic plasticity : Modulates synaptic strength and structure
Hippocampal function : Involved in learning and memory
Neuromuscular junction : Regulates postsynaptic specializations
Glial Function
Astrocyte function : Promotes astrocyte migration and process extension
Oligodendrocyte development : Supports myelination
Schwann cell function : Peripheral nerve regeneration
Role in Disease
Glioma Tenascin-C is highly expressed in gliomas:
Tumor progression : Promotes invasion and angiogenesis
Biomarker : Potential diagnostic and prognostic marker
Therapeutic target : Antibody-based therapies in development
Alzheimer's Disease
Re-expressed in AD brains
Co-localizes with amyloid plaques
May influence plaque formation or glial response
Multiple Sclerosis
Expressed in demyelinating lesions
Promotes glial scarring
May inhibit remyelination
Spinal Cord Injury
Up-regulated after injury
Dual role: promotes regeneration vs. forms glial scar
Target for regenerative therapies
Therapeutic Implications
Protein-Protein Interactions Tenascin-C interacts with:
Integrins : α8β1, αvβ3, α9β1, αvβ6
Fibronectin : ECM network formation
Heparin/heparan sulfate : ECM binding
NG2 proteoglycan : Pericyte interactions
See Also
[Extracellular Matrix Proteins](/proteins/extracellular-matrix)
[Astrocytes in Neurodegeneration](/cell-types/astrocytes)
[Glioma](/diseases/glioma)
[Synaptic Plasticity](/mechanisms/synaptic-plasticity)
References
[Chiquet-Ehrismann R et al., Tenascin-C: an ECM protein with diverse functions (2014) (2014)](https://doi.org/10.1016/j.matbio.2014.03.001)
[Jones FS et al., Tenascin-C in neural development (2000) (2000)](https://doi.org/10.1016/S0165-5728(00)
[Midwood KS et al., Tenascin-C as a therapeutic target (2011) (2011)](https://doi.org/10.1038/nrd3116)
[Huang JY et al., Tenascin-C in gliomas (2016) (2016)](https://doi.org/10.1007/s11060-016-2136-7)
[Kawakami K et al., Tenascin-C in spinal cord injury (2019) (2019)](https://doi.org/10.1016/j.neuroscience.2019.04.023)
Show full description